Skip to Main Content

Print | Bookmark | Font Size: + |

May 27, 2015

Open Meeting: Draft Local Coverage Determinations — June 16th, 2015

CGS will host a Joint Kentucky and Ohio Open Meeting for comments from providers and the general public related to the development of Local Coverage Determinations (LCDs) for Medicare Jurisdiction 15 on June 16th, 2015 at the following time and location:

Date:

June 16th, 2015

Time:

4:00-4:30 p.m. ET

Place:

Bethesda Hospital North
10500 Montgomery Road
Cincinnati, Ohio 45242
Creekside E Conference Room
Parking: Visitor Parking is in the front lot
Enter through the main lobby, take the main elevators to the ground floor and the Creekside Conference Rooms are beyond the cafeteria.

Please note that this is an Open Meeting and not the Contractor Advisory Committee Meeting (CAC).

Please see the list of Draft LCDs to be presented to the CAC. You may follow this linkExternal Website to view the draft LCDs.

  1. DL36029-Controlled Substance Monitoring and Drugs of Abuse Testing
  2. DL36021 - Molecular Diagnostic Tests (MDTs)-several articles attached
  3. DL36139 - MoPath: Biomarkers in Cardiovascular Risk Assessment
  4. DL36115 - MoPath: BRCA1 and BRCA2 Genetic Testing
  5. DL36127 - MoPath: Breast Cancer Assay: Prosigna
  6. DL36004 - MoPath: Breast Cancer Index℠ Genetic Assay
  7. DL36006 - MoPath: ConfirmMDx Epigenetic Molecular Assay
  8. DL36009 - MoPath: Decipher® Prostate Cancer Classifier Assay
  9. DL36117 - MoPath: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
  10. DL35984 - MoPath: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
  11. DL36206 - MoPath: Genomic Health™ Oncotype DX® Prostate Cancer Assay (DL36206 should populate to the CMS website on 05/28/2015.)
  12. DL36048 - MoPath: HLA-B*15:02 Genetic Testing
  13. DL36113 - MoPath: MGMT Promoter Methylation Analysis
  14. DL36011 - MoPath: Molecular RBC Phenotyping
  15. DL36174 - MoPath: NSCLC, Comprehensive Genomic Profile Testing
  16. DL36002 - MoPath: Prolaris™ Prostate Cancer Genomic Assay
  17. DL35986 - MoPath: Special Histochemical Stains and Immunohistochemical Stains
  18. DL35982 - Transcranial Magnetic Stimulation (TMS)

Interested parties who wish to make presentations related to the draft LCD(s) must submit a written request, no later than June 10th, 2015 to CMD.Inquiry@cgsadmin.com and include the following information:

  • Name, address, telephone number and e-mail address of presenter
  • Name, address, telephone number and e-mail address of organization
  • Name of draft LCD
  • Copy of the presentation

The presentation must be attached to your request. Each presentation will be limited to 10 minutes.

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved